How to Bring Dignity to Disability Care? Put the Person First
Group homes with a designated family doctor are a great solution for adults with intellectual and developmental disabilities (IDD).
University of California San Francisco
Give to UCSF
Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s
Survivors of Severe COVID Face Persistent Health Problems
A study reveals the life-altering impact of COVID-19 on individuals who developed severe illness, the majority of whom had to be placed on mechanical ventilators. Two-thirds still had physical, psychiatric, and cognitive problems for up to a year later.
Just Ask: Patients in the ER Are Willing to Get a Flu Shot
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.
COVID Vaccines Are Safe for Pregnant Women and Babies
A first of its kind study finds that the COVID vaccine is safe to administer during pregnancy, causing no abnormal delays when the infants were tested at 12 months and again at 18 months.
I’m a Microplastics Researcher. Here’s How To Limit Their Dangers
Tracey Woodruff, PhD, MPH, offers insights on what her research on microplastics has led her to change how she and her family eats and what cleaning products she uses.
Telehealth is as Safe as a Visit to the Clinic for Abortion Pills
Medication abortion can be delivered safely and effectively through telemedicine, according to new research that comes as the U.S. Supreme Court is about to hear a case that could severely restrict access to one of the two pills that are used to induce abortions.
Survey Shows Physicians Don’t Understand FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
COVID-19 Variant JN.1 is on the Rise. Here’s What to Know.
The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the United States. Three UCSF experts offer advice on vaccines, masking, and other ways to protect yourself.
